modelN05AL01
Extends from Pharmacokinetic.Models.PK_1C_enteral.
Information
| name: | Sulpiride | |
| ATC code: | N05AL01 | route: | oral |
| compartments: | 1 | |
| dosage: | 200 | mg |
| volume of distribution: | 0.78 | L |
| clearance: | 392 | mL/min |
| other parameters in model implementation | ||
Sulpiride is a substituted benzamide antipsychotic used primarily in the treatment of schizophrenia and, to a lesser extent, depression and other psychiatric disorders. It is still used in some countries, although its usage has declined in favor of other antipsychotics.
Pharmacokinetics
Pharmacokinetic parameters in healthy adult volunteers after oral administration.
References
Hamon-Vilcot, B, et al., & Piette, F (1998). Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers. European journal of clinical pharmacology 54(5) 405–409. DOI:10.1007/s002280050483 PUBMED:https://pubmed.ncbi.nlm.nih.gov/9754984
Cao, SS, et al., & Zhang, BK (2017). Pharmacokinetics and relative bioavailability of a generic amisulpride tablet in healthy Chinese volunteers . International journal of clinical pharmacology and therapeutics 55(10) 825–831. DOI:10.5414/CP203000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28793958
Täubel, J, et al., & Camm, AJ (2017). Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects. British journal of clinical pharmacology 83(2) 339–348. DOI:10.1111/bcp.13128 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27618796
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.9 | Volume of distribution (L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 0.8 | bioavailiability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 20 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1000 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Pharmacolibrary.Types.TransferRate | ka (from PK_1C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_1C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | elimination half-life |
Revisions
- 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)